Sigmund D A, Flessa H C
Department of Internal Medicine, University of Cincinnati College of Medicine, OH 45267-0562, USA.
Bone Marrow Transplant. 1995 Apr;15(4):647-8.
A patient with well-documented hypereosinophilic syndrome who underwent successful allogeneic bone marrow transplantation (BMT) is reported. This therapeutic modality should be considered in patients who fail standard therapy. End-organ damage may be reversible to some extent, and should not exclude patients from consideration of BMT.
报告了一名患有记录详尽的嗜酸性粒细胞增多综合征且接受异基因骨髓移植(BMT)成功的患者。对于标准治疗失败的患者,应考虑这种治疗方式。终末器官损害在一定程度上可能是可逆的,不应将患者排除在考虑进行BMT之外。